Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -8.272.0011.90-5.320.04

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -8.27 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32
Mar20200.04

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32
Negative
Mar2020 0.04 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹575.9 Cr -1.7% -19.3% -21.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -3.4% -0.2% 18.1% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.3% 3.4% 55.5% Stock Analytics
CIPLA ₹119,410.0 Cr -2.6% -0.6% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -2.3% -2.1% 20.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -2.9% -0.2% -8.7% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-1.7%

-19.3%

-21.4%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses